Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Mele

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Neurology|June 18, 2025
Long-Term Detection of Subclinical Atrial Fibrillation in Cryptogenic Stroke Patients With Insertable Cardiac MonitorsLeonardo Pantoni, Francesco Mele, Francesca Pescini, et al.
Journal of Cardiovascular Electrophysiology|March 20, 2026
Progression to Higher Burden of ICM-Detected Subclinical Atrial Fibrillation in Cryptogenic Stroke PatientsGiulio Molon, Alessandro Adami, Giovanni Forleo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2025
Patterns and predictors of statin therapy after ischemic stroke and TIA: insights from the LIPYDS multicenter studyAngelo Cascio Rizzo, Ghil Schwarz, Matteo Paolucci, et al.
JAMA Neurology|November 29, 2024
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASILGido Gravesteijn, Julie W Rutten, Minne N Cerfontaine, et al.
European Stroke Journal|July 15, 2023
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM studyMaurizio Paciaroni, Valeria Caso, Michele Romoli, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Neurology|June 18, 2025
Long-Term Detection of Subclinical Atrial Fibrillation in Cryptogenic Stroke Patients With Insertable Cardiac MonitorsLeonardo Pantoni, Francesco Mele, Francesca Pescini, et al.
Journal of Cardiovascular Electrophysiology|March 20, 2026
Progression to Higher Burden of ICM-Detected Subclinical Atrial Fibrillation in Cryptogenic Stroke PatientsGiulio Molon, Alessandro Adami, Giovanni Forleo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2025
Patterns and predictors of statin therapy after ischemic stroke and TIA: insights from the LIPYDS multicenter studyAngelo Cascio Rizzo, Ghil Schwarz, Matteo Paolucci, et al.
JAMA Neurology|November 29, 2024
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASILGido Gravesteijn, Julie W Rutten, Minne N Cerfontaine, et al.
European Stroke Journal|July 15, 2023
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM studyMaurizio Paciaroni, Valeria Caso, Michele Romoli, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Pageof 3